The Vision Research Center at UMKC (VRC) is the Department of Ophthalmology’s research arm, offering comprehensive research opportunities—including basic research, translational research, and clinical trials– to residents and fellows.
At the VRC, we maintain a strong tradition of being the first in the development of new clinical therapies and new tools that aid clinicians in treating patients who suffer from eye conditions. The Department has served as a host site for numerous sponsored clinical trials since its early days. It was the first in the world to successfully perform excimer laser surgery with a commercial instrument.
Founded in 2007 with the establishment of the Felix and Carmen Sabates Missouri Endowed Chair in Vision Research, the VRC’s Basic and Translational Research Programs are at the cutting edge of vision research, attracting the brightest minds in the field to test new ideas and concepts using state-of-the-art equipment to develop cures for diseases that affect the retina, including age-related macular degeneration, diabetic retinopathy, and glaucoma.
The effects of these blinding diseases will continue to impact a significantly greater number of people. With an aging Baby Boomer population, and the prevalence of eye-related disorders due to age, diabetes, and other conditions, the work of the VRC is paramount.
Our research is vigorous. Not only do we test new ideas and concepts in our basic research, we also take knowledge and treatments already available and improve them through translational research. In this way, our research goes from bench to bedside in the form of therapies and techniques to improve patients’ lives.
Our current research efforts for age-related macular degeneration, diabetic retinopathy, and glaucoma will allow us to advance the research further in the hope of developing cures.
Technology used in eye exams called microperimetry could prove to be an effective, non-invasive method of identifying early symptoms of multiple sclerosis. An article recently published by researchers at the…
UMKC School of Medicine vision researcher Peter Koulen, Ph.D., has received a $1.16 million grant for a study to battle vision loss and blindness. Backed by the National Institutes of…
Backed by a $1.16 million grant from the National Institutes of Health, UMKC School of Medicine vision researcher Peter Koulen, Ph.D., is studying new chemical compounds to treat and prevent…